Two more big pharma vets at Roche, AstraZeneca make the leap to top biotech R&D jobs as the great migration continues
A pair of prominent biotech poachers have claimed two more marquee names from the ranks of big pharma R&D.
David Berman, who until recently was head of I/O research at AstraZeneca, has been bumped up to the top job in R&D at Immunocore, the TCR biotech which recently recruited MedImmune chief Bahija Jallal as CEO. And Omar Khwaja has jumped from his post as global head of Roche’s neuroscience translational medicine group as well as rare diseases to Voyager $VYGR, where he’ll be CMO.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.